Literature DB >> 6845388

Improvement of Malayan cobra (Naja naja sputatrix) antivenin.

N H Tan.   

Abstract

A low molecular weight toxic fraction was isolated from venom of the Malayan cobra (Naja naja sputatrix) by Sephadex G-50 gel filtration chromatography. The fraction accounted for almost 100% of the venom lethality. Antisera were prepared by immunizing rabbits with the low molecular weight toxic fraction, the glutaraldehyde-treated low molecular weight toxic fraction and the glutaraldehyde-treated, sea snake neurotoxin-enriched low molecular weight toxic fraction, respectively. Only the serum of rabbits immunized with the glutaraldehyde-treated, neurotoxin-enriched fraction gave effective protection against high doses of Malayan cobra venom. This antiserum is thus a potent Malayan cobra antivenin. One milliliter of this antiserum was able to neutralize 1.5 mg of Malayan cobra venom. It is thus 4-8 times more potent than the commercially available Malayan cobra antivenins produced by immunizing horses with whole Malayan cobra venom.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6845388     DOI: 10.1016/0041-0101(83)90051-x

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  3 in total

1.  Venom and Purified Toxins of the Spectacled Cobra (Naja naja) from Pakistan: Insights into Toxicity and Antivenom Neutralization.

Authors:  Kin Ying Wong; Choo Hock Tan; Nget Hong Tan
Journal:  Am J Trop Med Hyg       Date:  2016-03-28       Impact factor: 2.345

2.  Toxinology provides multidirectional and multidimensional opportunities: A personal perspective.

Authors:  R Manjunatha Kini
Journal:  Toxicon X       Date:  2020-05-11

3.  Neutralization of the Principal Toxins from the Venoms of Thai Naja kaouthia and Malaysian Hydrophis schistosus: Insights into Toxin-Specific Neutralization by Two Different Antivenoms.

Authors:  Kae Yi Tan; Choo Hock Tan; Shin Yee Fung; Nget Hong Tan
Journal:  Toxins (Basel)       Date:  2016-03-26       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.